Dr. Taylor on the Future of Treatments for Endometrial Cancer

Alexandra Taylor, MD
Published: Monday, Feb 05, 2018



Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the future of treatments for patients with endometrial cancer.

There are exciting treatments coming forward, both in terms of systemic targeted agents and new radiotherapy and surgical techniques. Therefore, Taylor hopes that we can look forward to optimizing these approaches. The other take-home message, Taylor says, is the importance of assessing patients and developing strategies that look to work with patients in terms of quality of life.

Taylor is interested in looking at the new techniques of management of patients with recurrent disease, especially with local therapies. Physicians have been concentrating on the management of systemic treatment and are looking for radiation techniques—specifically stereotactic radiotherapy as a way of significantly improve our local control of recurrent or inoperable disease while minimizing toxicity. This is being developed in new clinical trials.


Alexandra Taylor, MD, consultant, clinical oncology, The Royal Marsden Hospital, discusses the future of treatments for patients with endometrial cancer.

There are exciting treatments coming forward, both in terms of systemic targeted agents and new radiotherapy and surgical techniques. Therefore, Taylor hopes that we can look forward to optimizing these approaches. The other take-home message, Taylor says, is the importance of assessing patients and developing strategies that look to work with patients in terms of quality of life.

Taylor is interested in looking at the new techniques of management of patients with recurrent disease, especially with local therapies. Physicians have been concentrating on the management of systemic treatment and are looking for radiation techniques—specifically stereotactic radiotherapy as a way of significantly improve our local control of recurrent or inoperable disease while minimizing toxicity. This is being developed in new clinical trials.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Publication Bottom Border
Border Publication
x